Xstrahl Medical (Booth 20) will introduce the exciting new Photoelectric Therapy system at the 8th UK Radiation Oncology (UKRO) Conference from the 8th to 10th of June at the Ricoh Arena, Coventry.
Xstrahl will attend this year’s Deutschen Gesellschaft für Radioonkologie e.V. (DEGRO) in Hamburg, Germany from 25th – 28th June. There will be 4,000 attendees from around Europe looking to get the latest information and technology in the name of science.
PURPOSE: To develop and test the suitability and performance of a comprehensive quality assurance (QA) phantom for the Small Animal Radiation Research Platform (SARRP). METHODS AND MATERIALS: A QA phantom was developed for carrying out daily, monthly and annual QA...
The purpose of this study was to empirically characterize and validate a kilovoltage (kV) X-ray beam source model of a superficial X-ray unit for relative dose calculations in water and assess the accuracy of the British Journal of Radiology Supplement 25 (BJR 25)...
OBJECTIVE: To evaluate the feasibility and accuracy of using cone beam CT (CBCT) scans obtained in radiation studies using the small-animal radiation research platform to perform semi-automatic tumour segmentation of pre-clinical tumour volumes. METHPOD: Volume...
Primary cutaneous lymphomas are a heterogeneous group of diseases. They often remain localized, and they generally have a more indolent course and a better prognosis than lymphomas in other locations. They are highly radiosensitive, and radiation therapy is an...
PURPOSE: The cone beam computed tomography (CBCT) guided small animal radiation research platform (SARRP) has been developed for focal tumor irradiation, allowing laboratory researchers to test basic biological hypotheses that can modify radiotherapy outcomes in ways...
Xstrahl Medical will introduce the exciting new Photoelectric Therapy system to the European Market at the start of the 3rd European Society for Radiotherapy and Oncology (ESTRO) forum in Barcelona, Spain on Friday 24th April. Xstrahl (Stand 3700) have worked with clinicians to develop a system that will allow an even greater number of patients to choose this surgery free, non-invasive treatment option.
PURPOSE: We aimed to characterise magnetic nanoparticle hyperthermia (mNPH) with radiation therapy (RT) for prostate cancer. METHODS: Human prostate cancer subcutaneous tumours, PC3 and LAPC-4, were grown in nude male mice. When tumours measured 150 mm3 magnetic iron...
Contact Us